de Juan C, Benito M, Fabregat I
Departamento de Bioquímica y Biología Molecular, Centro Mixto C.S.I.C./U.C.M. Facultad de Farmacia, Ciudad Universitaria, Madrid, Spain.
J Cell Physiol. 1992 Jul;152(1):95-101. doi: 10.1002/jcp.1041520113.
Sustained production of plasma proteins, notably albumin, is a reliable indicator of the differentiated state of hepatocytes. In this work, we have developed a fetal hepatocyte culture system where studying the regulation of albumin expression in proliferating liver cells. Our results show that under proliferative conditions (i.e., in the presence of EGF) fetal hepatocytes maintain albumin production above control quiescent non-treated cells. Glucagon and noradrenaline have no effect on the proliferation induced by EGF in cultured fetal hepatocytes; however, they act synergistically with the growth factor, increasing intracellular albumin levels. The maximum response is obtained by treatment of cells with EGF and noradrenaline. The stimulatory noradrenergic effect is mimicked by agents that increase cyclic AMP levels (forskolin plus IBMX). However, vasopressin or phorbol esters have no effect on albumin production, neither alone nor in combination with EGF. Dexamethasone, which does not alter the proliferative induction of EGF, increases albumin content. This effect is independent of the proliferative status of the cells and is not enhanced by glucagon, noradrenaline, or cyclic AMP increasing agents. The hormonal changes observed in albumin production partially correlate with changes in mRNA levels. This is the first time that cyclic AMP increasing agents are shown to act synergistically with EGF, increasing the expression of this liver specific gene.
血浆蛋白,尤其是白蛋白的持续产生是肝细胞分化状态的可靠指标。在这项工作中,我们开发了一种胎儿肝细胞培养系统,用于研究增殖肝细胞中白蛋白表达的调控。我们的结果表明,在增殖条件下(即存在表皮生长因子[EGF]),胎儿肝细胞的白蛋白产生量高于未处理的静止对照细胞。胰高血糖素和去甲肾上腺素对培养的胎儿肝细胞中EGF诱导的增殖没有影响;然而,它们与生长因子协同作用,增加细胞内白蛋白水平。用EGF和去甲肾上腺素处理细胞可获得最大反应。增加环磷酸腺苷(cAMP)水平的试剂(福斯高林加异丁基甲基黄嘌呤[IBMX])可模拟去甲肾上腺素的刺激作用。然而,血管加压素或佛波酯对白蛋白产生没有影响,单独使用或与EGF联合使用均无影响。地塞米松不改变EGF的增殖诱导作用,但可增加白蛋白含量。这种作用与细胞的增殖状态无关,胰高血糖素、去甲肾上腺素或增加cAMP的试剂也不会增强这种作用。在白蛋白产生中观察到的激素变化与mRNA水平的变化部分相关。这是首次表明增加cAMP的试剂与EGF协同作用,增加这种肝脏特异性基因的表达。